Size‐Confined Effects of Nanostructures on Fibronectin‐Induced Macrophage Inflammation on Titanium Implants

Advanced healthcare materials - Tập 10 Số 20 - 2021
Haoning Qi1, Miusi Shi1, Yueqi Ni1, Wenting Mo1, Peng Zhang1, Shuting Jiang1, Yufeng Zhang2,1, Xuliang Deng3
1The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei MOST) & Key Laboratory of Oral Biomedicine Ministry of Education School & Hospital of Stomatology Wuhan University Wuhan 430079 P. R. China
2Medical Research Institute, School of Medicine, Wuhan University, Wuhan, 430071 P. R. China
3National Engineering Laboratory for Digital and Material Technology of Stomatology, NMPA Key Laboratory for Dental Materials, Beijing Laboratory of Biomedical Materials & Beijing Key Laboratory of Digital Stomatology, Peking University School and Hospital of Stomatology, Beijing, 100081 P. R. China

Tóm tắt

Abstract

Macrophage activation determines the fate of biomaterials implantation. Though researches have shown that fibronectin (FN) is highly involved in integrin‐induced macrophage activation on biomaterials, the mechanism of how nanosized structure affects macrophage behavior is still unknown. Here, titanium dioxide nanotube structures with different sizes are fabricated to investigate the effects of nanostructure on macrophage activation. Compared with larger sized nanotubes and smooth surface, 30 nm nanotubes exhibit considerable lesser pro‐inflammatory properties on macrophage differentiation. Confocal protein observation and molecular dynamics simulation show that FN displays conformation changes on different nanotubes in a feature of “size‐confined,” which causes the hiding of Arg‐Gly‐Asp (RGD) domain on other surfaces. The matching size of nanotube with FN allows the maximum exposure of RGD on 30 nm nanotubes, activating integrin‐mediated focal adhesion kinase (FAK)‐phosphatidylinositol‐3 kinase γ (PI3Kγ) pathway to inhibit nuclear factor kappa B (NF‐κB) signaling. In conclusion, this study explains the mechanism of nanostructural‐biological signaling transduction in protein and molecular levels, as well as proposes a promising strategy for surface modification to regulate immune responses on bioimplants.

Từ khóa


Tài liệu tham khảo

10.1016/j.smim.2007.11.004

10.1038/nbt1055

10.1016/j.actbio.2012.06.010

10.1038/nnano.2010.250

10.1016/j.actbio.2015.08.033

10.1083/jcb.139.2.563

10.1016/j.biomaterials.2014.01.007

10.1002/adhm.201800675

10.1016/j.cyto.2011.06.020

10.1016/j.biomaterials.2020.120498

10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.0.CO;2-Z

10.1039/C8TB01675E

10.1039/C2BM00079B

10.1002/jemt.20854

10.1021/jp058101c

10.1038/nri3070

10.1146/annurev.immunol.15.1.323

10.1080/10409238.2016.1184224

10.1126/science.2821619

10.1039/C5CS00190K

10.1002/anie.201712448

10.1002/anie.201710642

10.1021/acs.langmuir.8b01937

10.1182/blood.2019004230

10.1038/nmat5023

10.1016/j.cell.2019.04.037

10.1038/nature19834

10.1038/nri910

10.1002/jcc.20291

10.1002/jcc.20090

10.1016/0022-2836(94)90013-2

10.1080/08927029108022432

10.1063/1.470117